Arizona Bill: HB 2415

Bill Summary

This bill aims to regulate kratom products in Arizona by amending existing laws and adding new provisions. It redefines "kratom" and "kratom product" to include ingestible or inhalable items made from the kratom plant (Mitragyna speciosa) and mandates that these products must be labeled with their ingredients, the quantity of key compounds like mitragynine and 7-hydroxymitragynine, and recommended serving sizes.

Why It Matters to MAHA

HB2415 represents a balanced approach that preserves adult access to kratom while establishing transparent, science-based standards that MAHA supports. Rather than banning kratom outright, as many states have done, Arizona takes a health freedom approach by allowing consenting adults to purchase and use the product while requiring clear labeling and ingredient disclosure so consumers can make informed decisions. The bill respects patient autonomy by rejecting federal overreach and maintaining state-level control over kratom policy, refusing to preemptively classify it as a narcotic drug. The transparency requirements, including mandatory disclosure of active compound quantities and recommended serving sizes, empower consumers with the information they need to evaluate products and determine appropriate usage for their own health needs. This model demonstrates how smart regulation can protect public health, especially regarding youth access, without eliminating patient choice or innovation in the botanical supplement market.